Phase IIa open-label dose-escalation pilot study using allogeneic human dermal fibroblasts for nasolabial folds.

  • Hypothermic, Journal Articles

Lowe NJ, Lowe PL, St. Clair Roberts J. Phase IIa Open-Label Dose-Escalation Pilot Study Using Allogeneic Human Dermal Fibroblasts for Nasolabial Folds. Dermatologic Surgery. (2010). Volume 36, Issue 10, October 2010, Pages: 1578–1585. Epub 2010 Aug 16. DOI:10.1111/j.1524-4725.2010.01686.x.

Date

BioLife Solutions logo

This website uses cookies to ensure you get the best experience on our website.

Accept & close